Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
INCY
INCY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
INCY News
Mirum and Incyte Report Positive Phase 2 Data for Zilurgisertib
5d ago
seekingalpha
Mirum and Incyte Announce New Progress in FOP Treatment
5d ago
Yahoo Finance
Mirum and Incyte Announce FOP Study Results
5d ago
Newsfilter
INCA033989 Shows Promising Clinical Benefits in Myelofibrosis and Essential Thrombocythemia
6d ago
Newsfilter
frontMIND Study Shows Tafa-Len-R-CHOP Significantly Improves Survival Rates
Jun 13 2026
Newsfilter
Incyte Acquires Vega Therapeutics for $1.25 Billion
Jun 08 2026
seekingalpha
Incyte Nears $2 Billion Acquisition of Star Therapeutics
Jun 07 2026
seekingalpha
Global X Uranium ETF Underperforms
Jun 03 2026
NASDAQ.COM
Incyte's Monjuvi Becomes First-Line Treatment for Lymphoma
May 30 2026
seekingalpha
Phase 3 frontMIND Study Shows New Therapy Improves Lymphoma Outcomes
May 30 2026
Newsfilter
Incyte and Genesis Expand AI Drug Discovery Partnership
May 20 2026
seekingalpha
Incyte Grants Equity Inducement Awards to New CFO Suketu Upadhyay
May 06 2026
Newsfilter
NIKTIMVO Approved in Australia for Chronic Graft-Versus-Host Disease Treatment
May 03 2026
Newsfilter
Incyte Receives FDA Approval for Jakafi XR
May 02 2026
NASDAQ.COM
FDA Approves Jakafi XR for Myelofibrosis and GVHD Treatment
May 01 2026
Newsfilter
Incyte Reports Strong Q1 2026 Earnings with Strategic Growth Plans
Apr 28 2026
seekingalpha
Show More News
